Cleared Abbreviated

K223376 - Monoject Magellan Insulin Safety Syringe 1mL, 31G x 6mm (8881893110) (FDA 510(k) Clearance)

Also includes:
Monoject Magellan Insulin Safety Syringe 0.5mL, 31G x 6mm (8881893150) Monoject Magellan Insulin Safety Syringe 0.3mL, 31G x 6mm (8881893130)
Jun 2023
Decision
229d
Days
Class 2
Risk

K223376 is an FDA 510(k) clearance for the Monoject Magellan Insulin Safety Syringe 1mL, 31G x 6mm (8881893110). This device is classified as a Syringe, Antistick (Class II - Special Controls, product code MEG).

Submitted by Cardinal Health200, LLC (Waukegan, US). The FDA issued a Cleared decision on June 21, 2023, 229 days after receiving the submission on November 4, 2022.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5860.

Submission Details

510(k) Number K223376 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 04, 2022
Decision Date June 21, 2023
Days to Decision 229 days
Submission Type Abbreviated
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code MEG — Syringe, Antistick
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5860